西班牙儿童PCV13接种后成人侵袭性肺炎链球菌病的血清型与基因型:ODIN研究
该研究对西班牙九家医院2010年8月至2015年6月住院成人(≥18岁)培养确诊的侵袭性肺炎链球菌病(IPD)进行前瞻性临床监测,共纳入1087例。常见血清型为3、19A、8等,疫苗型(PCV13+6C)占49.8%且五年间显著下降;疫苗型与肺炎(尤其复杂性肺炎)及免疫正常患者相关。
要点
- 成人IPD中疫苗型(PCV13+6C)占49.8%,五年间显著下降但仍较高。
- 常见血清型为3(12.7%)、19A(8.5%)、8(7.7%)。
- 疫苗型占肺炎53.9%、复杂性肺炎58.9%、<50岁成人53.4%、免疫正常者54.7%。
核心结论
- 尽管成人IPD中疫苗型比例显著下降,但仍维持在较高水平。
- 疫苗型与肺炎(特定血清型与复杂性肺炎)及免疫正常患者相关,提示PCV13血清型所致IPD负担。
研究设计与样本
- 前瞻性临床监测,纳入西班牙九家医院2010年8月至2015年6月住院成人(≥18岁)培养确诊的IPD。
- 共纳入1087例培养确诊的IPD发作。
主要发现
- 772例(71.0%)为菌血症性肺炎(其中复杂性肺炎401例、非复杂性371例),122例(11.2%)脑膜炎,102例(9.4%)无灶性菌血症,34例(3.1%)腹膜炎,57例(5.3%)其他。
- 最常见血清型为3(12.7%)、19A(8.5%)、8(7.7%)、7F(6.3%)、1(4.2%)、6C(4.2%)、11A(4.2%)、22F(4.2%)、14(4.0%)。
- 疫苗型(PCV13+6C)占49.8%,五年间显著下降,血清型6C和7F显著下降。
- 最常见基因型为CC180(8.4%)、CC191(6.0%)、CC53(5.0%)。
- 疫苗型占肺炎53.9%(414/768)、复杂性肺炎58.9%(235/399)、<50岁成人IPD 53.4%(143/268)、免疫正常患者54.7%(337/616)。
临床怎么用
- 成人IPD中疫苗型仍占较高比例,提示儿童PCV13接种对成人间接保护有限,需关注成人IPD防控。
- 疫苗型与肺炎及免疫正常患者相关,临床应重视PCV13血清型所致IPD负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Serotypes/genotypes causing invasive pneumococcal disease (IPD) in adults are determined by vaccination strategies. The aim of this study was to assess the epidemiology of IPD in adults (≥18 years) after PCV13 introduction for children: serotypes, clonal complexes, antibiotic non-susceptibility and clinical presentations. We performed a prospective, clinical surveillance of hospitalized culture-confirmed IPDs in adults in nine Spanish hospitals (August 2010-June 2015). A total of 1087 culture-confirmed IPD episodes were included, of which 772 (71.0%) had bacteremic pneumonia (401 complicated/371 uncomplicated pneumonia), 122 (11.2%) meningitis, 102 (9.4%) non-focal bacteremia, 34 (3.1%) peritonitis and 57 (5.3%) others. The most common serotypes were: 3 (12.7%), 19A (8.5%), 8 (7.7%), 7F (6.3%), 1 (4.2%), 6C (4.2%), 11A (4.2%), 22F (4.2%) and 14 (4.0%). Vaccine types (PCV13 + 6C) caused 49.8% of IPD episodes, with a significant decrease over the 5-year period, and significant decreases in serotypes 6C and 7F. The most common genotypes were: CC180 (8.4%), CC191 (6.0%), and CC53 (5.0%). Vaccine types caused 53.9% (414/768) pneumonia episodes and 58.9% (235/399) complicated pneumonia, 53.4% IPD in adults <50 years (143/268), and 54.7% IPD in immunocompetent patients (337/616). Overall non-susceptibility was 25.9% to penicillin (1.1% for parenteral criteria), 24.9% to erythromycin and 2.7% to levofloxacin. CONCLUSIONS: Although the percentage of vaccine-types causing IPDs in adults significantly decreased, it remained high. Associations of vaccine types with pneumonia (with complicated pneumonia for specific serotypes), and immunocompetent patients point to the burden of IPD caused by PCV13 serotypes.
引用
- Fenoll A, Ardanuy C, Liñares J, et al. Serotypes and genotypes of S. pneumoniae isolates from adult invasive disease in Spain: A 5-year prospective surveillance after pediatric PCV13 licensure. The ODIN study. Vaccine. 2018. PMID: 30449634. doi:10.1016/j.vaccine.2018.10.098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。